255 related articles for article (PubMed ID: 35013216)
1. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.
Torphy RJ; Sun Y; Lin R; Caffrey-Carr A; Fujiwara Y; Ho F; Miller EN; McCarter MD; Lyons TR; Schulick RD; Kedl RM; Zhu Y
Nat Commun; 2022 Jan; 13(1):97. PubMed ID: 35013216
[TBL] [Abstract][Full Text] [Related]
2. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
[TBL] [Abstract][Full Text] [Related]
3. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
4. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
Cueto FJ; Del Fresno C; Brandi P; Combes AJ; Hernández-García E; Sánchez-Paulete AR; Enamorado M; Bromley CP; Gomez MJ; Conde-Garrosa R; Mañes S; Zelenay S; Melero I; Iborra S; Krummel MF; Sancho D
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33980589
[TBL] [Abstract][Full Text] [Related]
5. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
Dangaj D; Bruand M; Grimm AJ; Ronet C; Barras D; Duttagupta PA; Lanitis E; Duraiswamy J; Tanyi JL; Benencia F; Conejo-Garcia J; Ramay HR; Montone KT; Powell DJ; Gimotty PA; Facciabene A; Jackson DG; Weber JS; Rodig SJ; Hodi SF; Kandalaft LE; Irving M; Zhang L; Foukas P; Rusakiewicz S; Delorenzi M; Coukos G
Cancer Cell; 2019 Jun; 35(6):885-900.e10. PubMed ID: 31185212
[TBL] [Abstract][Full Text] [Related]
6. CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells.
Hickman HD; Reynoso GV; Ngudiankama BF; Cush SS; Gibbs J; Bennink JR; Yewdell JW
Immunity; 2015 Mar; 42(3):524-37. PubMed ID: 25769612
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.
Campanella GS; Tager AM; El Khoury JK; Thomas SY; Abrazinski TA; Manice LA; Colvin RA; Luster AD
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4814-9. PubMed ID: 18347328
[TBL] [Abstract][Full Text] [Related]
8. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
[TBL] [Abstract][Full Text] [Related]
10. HPV16E7-Induced Hyperplasia Promotes CXCL9/10 Expression and Induces CXCR3
Kuo P; Tuong ZK; Teoh SM; Frazer IH; Mattarollo SR; Leggatt GR
J Invest Dermatol; 2018 Jun; 138(6):1348-1359. PubMed ID: 29277541
[TBL] [Abstract][Full Text] [Related]
11. STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells.
Yang H; Yamazaki T; Pietrocola F; Zhou H; Zitvogel L; Ma Y; Kroemer G
Cancer Res; 2015 Sep; 75(18):3812-22. PubMed ID: 26208907
[TBL] [Abstract][Full Text] [Related]
12. GPR182 is an endothelium-specific atypical chemokine receptor that maintains hematopoietic stem cell homeostasis.
Le Mercier A; Bonnavion R; Yu W; Alnouri MW; Ramas S; Zhang Y; Jäger Y; Roquid KA; Jeong HW; Sivaraj KK; Cho H; Chen X; Strilic B; Sijmonsma T; Adams R; Schroeder T; Rieger MA; Offermanns S
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33875597
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse.
McPhee CG; Duncan FJ; Silva KA; King LE; Hogenesch H; Roopenian DC; Everts HB; Sundberg JP
J Invest Dermatol; 2012 Jun; 132(6):1736-8. PubMed ID: 22358057
[No Abstract] [Full Text] [Related]
14. Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration.
Gordon-Alonso M; Hirsch T; Wildmann C; van der Bruggen P
Nat Commun; 2017 Oct; 8(1):793. PubMed ID: 28986561
[TBL] [Abstract][Full Text] [Related]
15. Exercise Training Improves Tumor Control by Increasing CD8
Gomes-Santos IL; Amoozgar Z; Kumar AS; Ho WW; Roh K; Talele NP; Curtis H; Kawaguchi K; Jain RK; Fukumura D
Cancer Immunol Res; 2021 Jul; 9(7):765-778. PubMed ID: 33839688
[TBL] [Abstract][Full Text] [Related]
16. LINC00152 mediates CD8
Ou J; Lei P; Yang Z; Yang M; Luo L; Mo H; Luo G; He J
J Mol Histol; 2021 Jun; 52(3):611-620. PubMed ID: 33709190
[TBL] [Abstract][Full Text] [Related]
17. Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.
Clancy-Thompson E; Perekslis TJ; Croteau W; Alexander MP; Chabanet TB; Turk MJ; Huang YH; Mullins DW
Cancer Immunol Res; 2015 Aug; 3(8):956-67. PubMed ID: 26048575
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors.
Bronger H; Magdolen V; Goettig P; Dreyer T
Cancer Metastasis Rev; 2019 Sep; 38(3):417-430. PubMed ID: 31482487
[TBL] [Abstract][Full Text] [Related]
20. Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rα
Kim SH; Cho E; Kim YI; Han C; Choi BK; Kwon BS
Nat Commun; 2021 Sep; 12(1):5314. PubMed ID: 34493727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
